NewsBenzinga报告称，Travere表示，PROTECT生物标志物数据进一步证明，与厄贝沙坦相比，FILSPARI在减少蛋白尿和减缓肾功能下降方面更优，支持其作为用于IgA肾病的非免疫抑制、靶向肾脏的基础一线治疗。 报告称，Travere表示，PROTECT生物标志物数据进一步证明，与厄贝沙坦相比，FILSPARI在减少蛋白尿和减缓肾功能下降方面更优，支持其作为用于IgA肾病的非免疫抑制、靶向肾脏的基础一线治疗。 Benzinga 2026.10.26 07:15 (GMT+0) Open on Benzinga Other news Support for semiconductor stocks could be as much as 15% lower than current levels, says Morgan Stanley Amcor’s Quarterly Earnings Preview: What You Need to Know Trader kimchi Adds Pump.fun Back to His Bio Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity Trader Mk4's NEAR long shows $12.15M unrealized profit, long position worth over $25M Baron Health Care Fund Q3 2026 Top Contributors And Detractors
Support for semiconductor stocks could be as much as 15% lower than current levels, says Morgan Stanley
Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity
